Avaliação histopatológica da cromoblastomicose: Uma revisão de literatura
DOI:
https://doi.org/10.33448/rsd-v10i6.16027Palavras-chave:
Cromoblastomicose; Diagnóstico; Histologia; Fungos; Técnica histológica.Resumo
A cromoblastomicose (CBM) é uma micose cutânea ou subcutânea. O trauma ocorre quando o fungo se instala e é mais prevalente em indivíduos que vivem em regiões tropicais e subtropicais, com as primeiras descrições datando de 1920. O diagnóstico de CBM é baseado na incidência de casos em áreas endêmicas e é comumente alcançado por meio microbiológico análises para identificar o agente etiológico em amostras clínicas. O processo de análise das amostras coletadas permite visualizar as células muriformes, que são estruturas castanhas, arredondadas, com câmaras cruzadas e que podem ser comumente chamadas de corpos escleróticos, caracterizando o diagnóstico positivo. O objetivo desta revisão foi verificar a conexão das técnicas histopatológicas com o diagnóstico de CBM.
Referências
Abdullah, E., Idris, A., & Saparon., A. (2017). Papr reduction using scs-slm technique in stfbc mimo-ofdm. ARPN Journal of Engineering and Applied Sciences 12(10):3218–3221.
Al-Doory, Y. (1983). Chromomycosis. In: Di Salvo, A. F. Occupational mycoses. Philadelphia: Lea & Febiger, 95-121.
Ameen, M. (2009). Chromoblastomycosis: clinical presentation and management. Clin Exp Dermatol; 34:849 – 854. https://doi.org/10.1111/j.1365-2230.2009.03415.x.
Azevedo, C. M. P. S., Marques, S. G., & Santos, D. W. C. L. (2015). Squamous cell carcinoma derived from chronic chromoblastomycosis in Brazil. Clinical Infectious Diseases, 60(10):1500–1504. https://doi.org/10.1093/cid/civ104.
Badali, H., Bonifaz, A., & Barrn-Tapia, T. (2010). Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis. Medical Mycology, 48(5):696–703. https://doi/org/10.3109/13693780903471073.
Badali, H., et al. (2008). Biodiversity of the genus Cladophialophora. Stud Mycol, 61(1):175-91. https://doi.org/10.3114/sim.2008.61.18.
Bhattacharjee, R., Narang, T., & Chatterjee, D. (2019). Cutaneous Chromoblastomycosis: A Prototypal Case. Journal of cutaneous medicine and surgery, 23(1):98-98. https://doi.org/10.1177/1203475418789029.
Bonifaz, A., Carrasco-Gerard, E., & Saul, A. (2010). Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses, 44:1-7. https://doi.org/ 10.1046/j.1439-0507.2001.00613. x.
Burlingame, E. A., et al. (2018). SHIFT: speedy histopathological-to-immunofluorescent translation of whole slide images using conditional generative adversarial networks. In: Medical Imaging 2018: Digital Pathology. International Society for Optics and Photonics, 1058105. https://doi.org/10.1117/12.2293249.
Camara-Lemarroy, C. R., Soto-Garcia, A. J., & Preciado-Yepez, C. I. (2013). Case of chromoblastomycosis with pulmonary involvement. Journal of Dermatology, 2013; 40(9):746–748. https://doi.org/10.1111/1346-8138.12216.
Chavan, S. S., Kulkarni., M. H., & Makannavar, J. H. (2010). “Unstained” and “de stained” sections in the diagnosis of chromoblastomycosis: a clinico-pathological study. Indian journal of pathology & microbiology, 53(4):666–671. https://doi.org/10.4103/0377-4929.72021.
Da Silva., et al. (2008). Development of natural culture media for rapid induction of Fonsecaea pedrosoi sclerotic cells in vitro. J Clin Microbiol, 46(11):3839-3841. https://doi.org/10.1128/JCM.00482-08.
De Azevedo., C. M., Gomes, R. R., & Vicente, V. A. (2015). Fonsecaea pugnacius, a novel agent of disseminated chromoblastomycosis. Journal of Clinical Microbiology, 53(8):2674–2685. https://doi.org/10.1128/JCM.00637-15.
De Hoog, G. S., et al. (2000). Black fungi: clinical and pathogenic approaches. Med Mycol, ;38:243-50.
Elfer, K. N., et al. (2016). DRAQ5 and eosin (‘D&E’) as an analog to hematoxylin and eosin for rapid fluorescence histology of fresh tissues. PLoS One, 11(10): e0165530. https://doi.org/10.1371/journal.pone.0165530.
Freudiger, C. W., et al. (2012). Multicolored stain-free histopathology with coherent Raman imaging. Laboratory investigation, 92(10):1492. https://doi.org/10.1038/labinvest.2012.109.
Gajjar, D. U., Pal, A. K., & Santos, J. M. (2011). Severe pigmented keratitis caused by Cladorrhinum bulbillosum. Indian J Med Microbiol, 29(4):434–437. https://doi.org/10.4103/0255-0857.90191. PMID: 22120812.
Galvão, T. F., & Pereira, M. G. (2014). Revisões sistemáticas da literatura: passos para sua elaboração. Epidemiologia e Serviços de Saúde, 23(1):183–184. https://doi.org/10.5123/S1679-49742014000100018.
Giacomelli, M. G., et al. (2016).Virtual hematoxylin and eosin transillumination microscopy using epi-fluorescence imaging. PLoS One, 11(8):e0159337. https://doi.org/10.1371/journal.pone.0159337.
Hay, R. (2019). The diagnosis of fungal neglected tropical diseases (fungal NTDs) and the role of investigation and laboratory tests: An expert consensus report. Tropical medicine and infectious disease, 4(4):122. https://doi.org/10.3390/tropicalmed4040122.
He, L., et al. (2018). Successful treatment of chromoblastomycosis of 10‐year duration due to Fonsecaea nubica. Mycoses, 61(4):231-236. https://doi.org/10.1111/myc.12732.
Jaleel, A., et al. (2017). Mycetoma‐like chromoblastomycosis: a diagnostic dilemma. International journal of dermatology, 56(5):563-566. https://doi.org/10.1111/ijd.13499.
Jamil, A., Lee, Y. Y., & Thevarajah, S. (2012). Invasive squamous cell carcinoma arising from chromoblastomycosis. Medical Mycology, 50(1):99–102. https://doi.org/10.3109/13693786.2011.571295.
Jayasree, P., et al. (2019). Dermoscopic features in nodular chromoblastomycosis. International journal of dermatology, 58(5):107-109. https://doi.org/10.1111/ijd.14344.
Kim, D. M., Hwang, S. M., & Suh, M. K. (2011). Chromoblastomycosis Caused by Fonsecaea pedrosoi. Annals of dermatology, 23(3):369–74. https://doi.org/10.5021/ad.2011.23.3.369
Lahiani, A. K., & Eldad, G. R. O. (2018). Enabling Histopathological Annotations on Immunofluorescent Images through Virtualization of Hematoxylin and Eosin. J Pathol Inform. https://doi.org/10.4103/jpi.jpi_61_17.
Le, Ta., et al. (2019). Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam, Mycopathologia, 184(1):115–119. 10.1007/s11046-018-0284-3.
López-Martínez., & Méndez-Tovar, L. J. (2007). Chromoblastomycosis. Clin Dermatol, 25:188–94. https://doi.org/10.1128/CMR.00032-16.
Lyon, J. P., et al. (2011). Photodynamic Antifungal Therapy Against Chromoblastomycosis. Mycopathologia, 172( 4):293–297. https://doi.org/10.1007/s11046-011-9434-6.
Mcginnis, M. R. (1983). Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol,8:1-16. https://doi.org/10.1016/s0190-9622(83)70001-0.
Mendoza, L., Karuppayil, S. M., & Szaniszlo, P. J. (1993). Calcium regulates in vitro dimorphism in chromoblastomycotic fungi. Mycoses, 36(5-6):157-64. 10.1111/j.1439-0507.1993.tb00744.x.
Mittal, A., et al. (2014). Chromoblastomycosis from a non-endemic area and response to itraconazole. Indian journal of dermatology, 59(6):606. https://doi.org/10.4103/0019-5154.143537.
Moher, D., Liberati, A., & Tetzlaff, J. (2009). Guidelines and Guidance Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med, 6: e1000097. https://doi.org/10.1186/2046-4053-4-1.
Pradeepkumar, N. S., & Joseph, N. M. (2011). Chromoblastomycosis caused by Cladophialophora carrionii in a child from India. Journal of Infection in Developing Countries, 5 (7):556–560. https://doi.org/10.3855/jidc.1392.
Purim, K. S. M., Peretti., M. C., & Neto, J. F. (2017). Chromoblastomycosis: Tissue modifications during itraconazole treatment. Anais Brasileiros de Dermatologia 2017; 92(4):478–483. https://doi.org/10.1590/abd1806-4841.20175466.
Queiroz-Telles, F., et al. (2009). Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol, 47:3-15. https://doi.org/10.1080/13693780802538001.
Queiroz-Telles, F., & Santos, D. W. (2013). Challenges in the therapy of chromoblastomycosis. Mycopathologia, 175:477-88. https://doi.org/10.1007/s11046-013-9648-x.
Queiroz-Telles, F., et al. (2011). Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment. Med Mycol, 49:225-36. https://doi.org/10.3109/13693786.2010.539631.
Stefanović, D. (2015). Use of eriochrome cyanine R for routine histology and histopathology: an improved dichromatic staining procedure. Biotechnic & Histochemistry, 90(6):470-474. https://doi.org/10.3109/10520295.2015.1058420.
Stefanović, D. S., & Marija, L. D. (2015). Use of eriochrome cyanine R in routine histology and histopathology: is it time to say goodbye to hematoxylin? Biotechnic & histochemistry, 90(6):461-469. https://doi.org/10.3109/10520295.2015.1057765.
Weedon, D., Deurse, M., & Allison, S. (2013). Chromoblastomycosis in Australia: An historical perspective. Pathology, 45(5):489–491. https://doi.org/10.1097/PAT.0b013e32836326a1.
Zhang, R., et al. (2019). A Case of Chromoblastomycosis Caused by Fonsecaea Pedrosoi and Investigation of the Pathogenic Fungi, Mycopathologia, 184(2):349-352. https://doi.org/10.1007/s11046-019-0319-4
Zhu, C. Y., Yang, Y. P., & Sheng, P. (2015). Cutaneous Chromoblastomycosis Caused by Veronaea botryosa in a Patient with Pemphigus Vulgaris and Review of Published Reports. Mycopathologia, 180(1–2):123–129. https://doi.org/10.1007/s11046-015-9887-0.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2021 Mateus Cardoso do Amaral; André dos Santos Carvalho; Even Herlany Pereira Alves; Hélio Mateus Silva Nascimento; Ayane Araújo Rodrigues; Vinicius da Silva Caetano; Bruno Costa Silva; Thayaná Ribeiro Silva Fernandes; Jacks Renan Neves Fernandes; Nathalia Thamires Duarte Sousa do Rêgo; Arisvelton Fernandes de Paiva; Clarissy Andrade Costa Medeiros; Sijomara Maria Costa Freitas; Maria Sarah de Macedo Machado; Daniel Fernando Pereira Vasconcelos
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
1) Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
2) Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
3) Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado.
